Expression of Polo-Like Kinase (PLK1) in non-Hodgkin's lymphomas

REFERENCES

• Fisher RI. Overview of non-Hodgkin's lymphoma: Biology, staging, and treatment. Seminars in Oncology 2003; 30\(Suppl. 4):3 — 9.
   Google Scholar
• The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112–2135.
   Google Scholar
• Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours: Pathology and Genetics: Heamatopoietic and Lymphoid Tissues. Lyon: IARC; 2001.
   Google Scholar
• Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994;4:1361–1392.
   Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;9:3909–3918.
   Google Scholar
• Nigg EA. Polo-like kinases: Positive regulators of cell division from start to finish. Current Opinions in Cell Biology 1998; 10:776–783.
   Google Scholar
• Glover DM, Hagan IM, Tavares AA. Polo-like kinases: A team that plays throughout mitosis. Genes and Development 1998;12:3777–3787.
   Google Scholar
• Llamazares S, Moreira A, Tavares A, Girdham C, Spruce BA, Gonzalez C, Karess RE, Glover DM, Sunkel CE. polo encodes a protein kinase homolog required for mitosis in Drosophila. Genes and Development 1991;5:2153–2165.
   Google Scholar
• Donaldson MM, Tavares AA, Hagan IM, Nigg EA, Glover DM. The mitotic roles of Polo-like kinase. Journal of Cell Science 2001;114:2357–2358.
   Google Scholar
• Holtrich U, Wolf G, Brauninger A, Kam T, Bohme B, Rubsamen-Waigmann H, Strebhardt K. Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proceedings of the National Academy of Sciences of the United States of America 1994;91:1736–1740.
   Google Scholar
• Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rubsamen-Waigmann H, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 1997;14:543–549.
   Google Scholar
• Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Research 1999;59:2794–2797.
   Google Scholar
• Tokumitsu Y, Mori M, Tanaka S, Akazawa K, Nakano S, Niho Y. Prognostic significance of polo-like kinase expres-sion in esophageal carcinoma. International Journal of Oncology 1999;15:687–692.
   Google Scholar
• Strebhardt K, Kneisel L, Linhart C, Bernd A, Kaufmann R. Prognostic value of polo-like kinase expression in melano-mas. Journal of the American Medical Association 2000;283: 479–480.
   Google Scholar
• Chan JA, Olvera M, Lai R, Naing W, Rezk SA, Brynes RK. Immunohistochemical expression of the transcription factor DP-1 and its heterodimeric partner E2F-1 in non-Hodgkin lymphoma. Applied Immunohistochemistry and Molecular Morphology 2002;10:322–326.
   Google Scholar
• Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Research 1971;31:1860–1861 .
   Google Scholar
• Takai N, Miyazaki T, Miyakawa I, Hamanaka R. Polo-like kinase expression in normal human endometrium during the menstrual cycle. Reproduction, Fertility, and Development 2000;12:59–67.
   Google Scholar
• Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Letters 2001;164:41–49.
   Google Scholar
• Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). British Journal of Haematology 1991;79:428–437.
   Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine 1993;329:987–994.
   Google Scholar
• Gascoyne RD, Adomat SA, Krajewski S, Krajewska M, Horsman DE, Tolcher AW, O'Reilly SE, Hoskins P, Goldman AJ, Reed JC, Connors JM. Prognostic significance of Bc1-2 protein expression and Bc1-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 1997;90: 244–251.
   Google Scholar
• Pins MA, Pezzella F, Martinez-Montero JC, Orradre JL, Villuendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B, Garrido MC, et al. p53 and bc1-2 expression in high-grade B-cell lymphomas: correlation with survival time. British Journal of Cancer 1994;69: 337–341.
   Google Scholar
• Yatabe Y, Nakamura S, Seto M, Kuroda H, Kagami Y, Suzuki R, Ogura M, Kojima M, Koshikawa T, Ueda R, Suchi T. Clinicopathologic study of PRADlicyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. American Journal of Surgical Pathology 1996;20: 1110–1122.
   Google Scholar
• Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel R1\4, Banks PM, Foucar K, Kjeldsberg CR, Levy N, Nathwani BN, et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lympho-mas: a prospective Southwest Oncology Group trial. Blood 1994;83: 1460–1466.
   Google Scholar
• Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfeld AG. The prognostic value of Ki67 immunos-taining in non-Hodgkin's lymphoma. Journal of Pathology 1988;154: 223–235.
   Google Scholar
• Hamanaka R, Maloid S, Smith MR, O'Connell CD, Longo DL, Ferris DK. Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase. Cell Growth and Differentiation 1994;5:249–257.
   Google Scholar
• Golsteyn R1\4, Schultz SJ, Bartek J, Ziemiecki A, Ried T, Nigg EA. Cell cycle analysis and chromosomal localization of human Plkl, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. Journal of Cell Science 1994;107: 1509–1517.
   Google Scholar
• Hamanaka R, Smith MR, O'Connor PM, Maloid S, Mihalic K, Spivak JL, Longo DL, Ferris DK. Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. Journal of Biological Chemistry 1995;270:21086–21091.
   Google Scholar
• Lane HA, Nigg EA. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plkl) in the functional maturation of mitotic centrosomes. Journal of Cell Biology 1996135:1701-1713.
   Google Scholar
• Smith MR, Wilson ML, Hamanaka R, Chase D, Kung H, Longo DL, Ferris DK. Malignant transformation of mam-malian cells initiated by constitutive expression of the polo-like kinase. Biochemical and Biophysical Research Commu-nications 1997;234:397–405.
   Google Scholar
• Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Polo-like kinase (PLK) expression in endome-trial carcinoma. Cancer Letters 2001;169:41–49.
   Google Scholar
• Macmillan JC, Hudson JW, Bull S, Dennis JW, Swallow CJ. Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer. Annals of Surgical Oncology 2001; 8:729–740.
   Google Scholar
• Takahashi T, Sano B, Nagata T, Kato H, Sugiyama Y, Kunieda K, Kimura M, Okano Y, Saji S. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Science 2003;94: 148–152.
   Google Scholar
• Wolf G, Hildenbrand R, Schwar C, Grobholz R, Kaufmann M, Stutte HJ, Strebhardt K, Bleyl U. Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer. Pathology Research and Practice 2000;196:753–759.
   Google Scholar
• Kneisel L, Strebhardt K, Bernd A, Wolter M, Binder A, Kaufmann R. Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. Journal of Cutaneous Pathology 2002;29:354–358.
   Google Scholar
• Schwartz BR, Pinkus G, Bacus S, Toder M, Weinberg DS. Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining. American Journal of Pathology 1989;134: 327–336.
   Google Scholar
• Caulet S, Lesty C, Raphael M, Binet JL, Diebold J. Quantitative study of 1I-67 antibody staining in non-Hodgkin's lymphomas using image analysis. Analytical and Quantitative Cytology and Histology 1991;13: 279–287.
   Google Scholar
• Yuan J, Horlin A, Hock B, Stutte HJ, Rubsamen-Waigmann H, Strebhardt K. Polo-like kinase, a novel marker for cellular proliferation. American Journal of Pathology 1997;150: 1165–1172.
   Google Scholar
• Zhang A, Ohshima K, Sato K, Kanda M, Suzumiya J, Shimazaki K, Kawasaki C, Kikuchi M. Prognostic clinico-pathologic factors, including immunologic expression in diffuse large B-cell lymphomas. Pathology International 1999;49:1043–1052.
   Google Scholar
• Lee WP. The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine. Cancer Letters 1993;73:105–111.
   Google Scholar